CA2022564C - Apparatus for repeated automatic execution of a thermal cycle for treatment of samples - Google Patents
Apparatus for repeated automatic execution of a thermal cycle for treatment of samplesInfo
- Publication number
- CA2022564C CA2022564C CA002022564A CA2022564A CA2022564C CA 2022564 C CA2022564 C CA 2022564C CA 002022564 A CA002022564 A CA 002022564A CA 2022564 A CA2022564 A CA 2022564A CA 2022564 C CA2022564 C CA 2022564C
- Authority
- CA
- Canada
- Prior art keywords
- pathway
- sample
- treatment
- thermal
- moving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
- B01L7/525—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples with physical movement of samples between temperature zones
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/08—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a stream of discrete samples flowing along a tube system, e.g. flow injection analysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/088—Channel loops
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00346—Heating or cooling arrangements
- G01N2035/00435—Refrigerated reagent storage
Abstract
Apparatus for repeated automatic execution of a thermal cycle for the treatment of a sample, especially a biological sample, comprises means (6) defining a pathway which is physically closed throughout the treatment and within which the sample is resident throughout the treatment. Means (3, 4, 11, 12) are provided to move the sample between different positions along the pathway and (7, 15, 16) to heat or cool the sample as a function of its position within the pathway.
Preferably the pathway is a capillary tube, which may be in spiral, closed loop or linear form. Heating and cooling means are provided by thermostated zones which may provide a continuous thermal gradient, regular or irregular, or be in a discontinuous arrangment. The preferred means of moving the samples is magnetic.
Preferably the pathway is a capillary tube, which may be in spiral, closed loop or linear form. Heating and cooling means are provided by thermostated zones which may provide a continuous thermal gradient, regular or irregular, or be in a discontinuous arrangment. The preferred means of moving the samples is magnetic.
Description
2 ~ 2 2~6 ~
The invention relates to apparatus for repeated automatic execution of a thermal cycle for the treatment of biological samples.
Such an apparatus has numerous applications in biology in general and microbiology in particular. In the latter field, the necessity of treating a biological sample at different temperatures is generally dictated by two basic biological characterics. First, the biological activity of an enzyme is greatly dependent on the temperature. In general, each enzyme has an optimum operating temperature and its activity decreases regularly if one moves away from this temperature. Curves showing the variations in biological activity as a function of temperature may thus be obtained and represent an important characteristic of each enzyme. Secondly, the reaction of molecular hybridisation between two sequences of nucleic acids is directly connected to the temperature. This hybridisation based on the complementarity of the bases between two sequences may occur between two molecules of deoxyribonucleic acid (DNA), between two molecules of ribonucleic acid (RNA) or between one molecule of DNA and one molecule of RNA. Molecular hybridisation enables one to produce either pairing by hydrogenous connection between two distinct molecules or intermolecular pairing between i, ~
~022~6~
two complementary sequences. In the latter case, there is the formation of a so-called secondary structure.of DNA or RNA molecules . The effect of temperature on the hybridisation reaction is essential and each sequence of DNA (or RNA) is defined by its Tm, ie: the temperature at which 50% of the sequences are paired to complementary sequences. The Tm of a precise sequence is evaluated experimentally following the hyperchromicity at 260 nm by spectro-photometry, which accompanies the unpairing (or denaturing) of two complementary sequences of DNA. The whole of the DNA sequences are in the single strand form at high temperature (100C) and the double strand form at low temperature (10-20C).
The Tm of a DNA sequence depends essentially on the following two parameters: the basic sequence and ionic force of the medium. The Tm usually found varies between 20 and 85C. Thus, the great majority of molecular reactions may be produced in perfectly defined and controlled thermal conditions. Certain of these reactions require the successive use of different temperatures and may be effected in the apparatus described in this invention. This particularly concerns hydrolysis using restriction enzymes, enzyme modification reactions for DNA, cascade enzyme reactions, the isolation of repetitive families of sequences for DNA and the amplification by 'polymerase chain reaction'. These applications will now be discussed in greater detail.
Hydrolysis of DNA by restriction enzymes A restriction enzyme enables one to cut a hybridisation duplex DNA/DNA at a very specific place defined by its sequence. For the great majority of these enzymes, the temperature of maximum activity is 37C. The incubation time of DNA with the enzyme at 37C varies between 30 min and several hours . Thus, a simple method of inactivating the enzyme consists of incubating the sample for several 2o2~64 \
-minutes at 100C, a temperature at which the enzyme is irreversibly denatured. This treatment is equally.effective in DNA denaturation which returns to its double strand form if it is subjected to progressive reduction of the temperature from 110C to 20C. Sudden cooling of the sample does not enable one to achieve correct renaturing of the DNA. Progressive cooling in particular may proceed by stages.
Generalisation of the set of enzyme treatments of DNA and lo RNA
This method applied for restriction enzymes may be adapted for the treatment of many enzymes, for example:
- polynucleotic kinases - ligases - the terminal deoxynucleotidyl transferase - DNA and RNA polymerases - endonucleases and exonucleases Cascade enzyme treatment Many successive enzyme treatments may be necessary to obtain one or more defined DNA sequences. A change of the reaction medium is generally necessary between two enzyme reactions.
Isolation of repetitive families of DNA sequences DNA sequences in large numbers exist in complex genomes (human genome = 3.5 x 10 basic pairs). It is possible to distinguish different repetitive families of sequences as a function of the number of copies of sequences per genome.
Thus, DNA genomes totally denatured thermally are restored in stages and in a selective manner. The very repetitive sequences are restored first (family 1), then the medium repetitive sequences (family 2), then the hardly repetitive sequences (family 3) and finally, the unique sequences (family 4). It is thus possible to isolate these i 2~2~
-different families by passing the sample into affinity columns of the hydroxy-apatite type, enabling one to separate single strand DNA molecules from double strand DNA
molecules. They are passed into the columns at a precise temperature during stage by stage cooling of the sample.
The temperature of the first column is around the melting temperature (Tm) of family 1 sequences. In these conditions, sequences of family 1 can be separated from sequences of families 2, 3 and 4. The same process is lo applied for separation of families 2, 3 and 4. The apparatus described in this invention is particularly well adapted to carry out this thermal sequence.
Amplification of the number of DNA sequences by 'Polymerase chain reaction' (PCR) This technique enables one specifically to amplify the number of copies of a double strand DNA sequence. The principle of PCR (R.K. Saiki et al, Science, 230, 198S, 1350-1354) is to use the activity of the DNA polymerase DNA
dependent initiating the synthesis starting from oligonucleotidic initial material (Pl and P2) added in the reaction medium. An amplification cycle consists of three successive stages:
- Staqe 1 Denaturing of the DNA with double strands at 90-lOO~C.
- Stage 2 Hybridisation of oligonucleotidic primers (15-35 nucleotides) P1 and P2 on the target sequences.
Pl hybridizes with the (+) strand and P2 hybridizes with the (-) strand. This stage is carried out at a temperature close to the mean of the Tm's of P1 and P2.
- Stage 3 Synthesis of the complementary DNA strand by extension of the primers Pl and P2, thanks to the activity of a DNA
polymerase. This stage takes place close to the optimum 1, 2 0 ~ J' ~ l~
operating temperature of the enzyme, either at 37C for the Klenow fragment or at 72C for the Tag polymerase~
Thus, after an amplification cycle, the number of sequences completed by Pl and P2 is multiplied by 2, multiplied by 4 after 2 cycles, by 8 after 3 cycles, by 1024 after 10 cycles and by 1,048,576 after 20 cycles. Generally, the rate of amplification after _ cycles is 2n. A cycle of amplification thus consists of 3 successive thermal stages and one complete PCR reaction requires about 10 to 60 cycles. Each thermal stage generally lasts from 1 to 5 mins. Automation of such a technique thus represents considerable progress.
The invention provides apparatus for repeated automatic execution of a thermal cycle for the treatment of a sample, the apparatus comprising means defining a pathway which is physically closed throughout the treatment and within which the sample is resident throughout the treatment, means for moving the sample between different positions along the pathway, and means for heating and cooling the sample as a function of its position within the pathway.
~he means defining the pathway preferably comprises a capillary tube. This may be of a semi-rigid material such as plastics material, and may be of small diameter, from approximately 0.1 mm to approximately 4 mm, preferably from 1 mm to 3 mm. Such a small internal cross-section ensures a large heat exchange surface to volume ratio, and therefore enables rapid temperature variations, particularly as compared to a sample in a conventional 0,5 to 1,5 ml tube. The sample treated in the apparatus of the invention is usually of from 1 to 50 microlitres.
Various spatial arrangements of the capillary tube are envisaged. It may, for instance, be in a spiral form, in a 2~225~
-closed loop form or in linear form. Each turn of the spiral, each turn of the closed loop or each passage of the length of linear capillary tube represents one thermal cycle, within which the sample passes through two or more thermostated zones, at different temperatures from 4C to 150C. Further thermal cycles, up to 100, comprise the next turn of spiral, a further turn within the closed loop, or the return of the sample in reverse direction along the length of the linear capillary tube.
lo The thermostated zones may be arranged on a discontinuous system or on a continuous system. In a discontinuous system, the zones are separated by a physical barrier, crossed only by the capillary tube. Each zone has an autonomous heating or cooling system. The inter-zone barrier isolates each zone from the thermal effect of the adjacent zone(s). In a continuous system there is no physical barrier. The capillary tube crosses a continuous and directional thermal gradient, which may be created in a liquid, gaseous or solid medium. A change of medium gives the possibility of a continuous but irregular thermal gradient.
The rate of movement of the sample through the capillary tube has a profound effect on the treatment. If the sample moves very slowly through a zone, its temperature will approach or reach the zone temperature. The sample may even be stopped within a given zone for a predetermined period, stabilising its temperature at that of the zone. on the other hand, if the sample moves rapidly through a zone, the thermal effect of that zone on the sample may be minimised or suppressed.
The movement of the sample in the capillary tube may be obtained in different ways:
- by at least one peristaltic pump acting on a capillary zone having a flexible wall;
2 ~ ~ 4 -- by displacement in a magnetic system consisting of two parts: .
of a magnet and of a party responding to the effect of the magnet (metal part or second magnet);
One of the parts is solidly connected to a mechanical drive system, enabling it to rotate (circular system) or to be displaced (linear system). The other part is situated inside the capillary and is solidly connected to the sample. This part may consist of at least one solid particle (globule, cylinder, suspension of microparticles in a liquid etc) or at least of one liquid particle.
- by the effect of at least one pump acting on a gas:
- by passive capillary action;
- by the effect of thermal pumping created by the proximity of gaseous masses at different temperatures inside the capillary.
The movement of the sample may also be obtained by a combination of two or more of these processes. The movement of the sample may be under microprocessor control.
The apparatus of the invention uses a semi-closed system, represented by the capillary, reducing the risk of molecular contamination during treatment of the biological sample.
The invention is illustrated with reference to the drawings, of which:
Figures la, lb and lc are schematic diagrams of the apparatus of the invention, showing the helical, closed loop and linear arrangements respectively of the capillary tube; Figure 2 is a cross-sectional view according to the section line II-II of Figure 3 of an apparatus according to the invention in which the capillary tube is of closed loop form; and Figure 3 is a sectional view of the apparatus of Figure 2, taken on the section line II-II of Figure 2.
2022S6~
Reffering first to Figure la-c, three schematic diagrams are presented. In each, there are three thermostated zones I, II and III through which the biological sample in the capillary tube passes in a single thermal cycle. The thermostatic zones I, II and III could be replaced by a continuous or discontinuous thermal gradient. In the spiral form of Figure la, there are as many loops as there are thermal cycles to be performed. In the closed loop form of Figure lb, there is just one loop and each thermal cycle consists of one circuit of the closed loop by the biological sample. In the linear form of Figure lc the first thermal cycle is completed by the passage of the sample from left to right, that is through thermostated zone I, thermostated zone II and thermostated zone III in i~ succession. The second thermal cycle is completed by the return passage of the sample from right to left, that is through thermostated zone III, thermostated zone II and thermostated zone I in succession. Each odd numbered cycle follows the pattern of the first and each even numbered cycle follows the pattern of the second. It is noted that the sample essentially passes through the thermostated zone II in each direction, so producing a succession of thermostated zones I, II, III, III, II, I, I, II, III, III, II, I........ However, the passage through thermostated zone II on even cycles can be completed quickly to minimise its effect, and the delay times in zones I and III adjusted to achieve the same I,II,III,I,II,III,I,II,III... effect as in the spiral and closed loop arrangements.
Reffering now to Figures 2 and 3, the apparatus illustrated shows a closed loop form of the apparatus of the invention, with a magnetic displacement system for the biological sample and a discontinuous system of thermostated zones.
The apparatus is provided with a capillary tube 6 in the form of a closed loop. The capillary tube 6 is provided with a branch e for entry of the sample to be treated, and with a branch s for removal of the sample after treatment.
~02256~
g A key 13 is movable along the axis B-B between a radially inward position, in which the capillary tube 6 is pressed against a wall 5, and a radially outward position, in which the capillary branches e and s are pressed against the elements 14. In the radially inward position, the capillary loop 6 is interrupted and the branches e and s are open for entry and removal of the sample. In the radially outward position the branches e and s are closed, and the sample is free to continue cycling around the closed loop capillary 6. The means for moving the key 13 are external to the apparatus described, and are not shown in the drawings.
For movement of the sample around the closed loop capillary 6, a magnetic system is used. This comprises a magnetic 4 carrled on an arm 2 fast with a drive shaft 3. The drive shaft 3 is journalled at 11 and powered by a motor 12.
Responsive to the effect of the magnetic 2 is a party formed by metallic micro-globules in suspension in mineral oil. This party is in the capillary tube 6 in abutment with the sample.
During one turn of the sample around the closed loop capillary 6, the sample passes close to thermostatic compartments 7, 15 and 16. The sample is under the thermal influence of the compartment in regard of which it finds itself for the time being. Each of these compartments 7, 15 and 16 is thermally regulated at a temperature between 4C
and 150C. The compartments are isolated from a brace 10, carried by a mounting plate 9, by an adjustable spacing 8.
The motor 12 is under the control of a programmable microprocessor, allowing various parameters associated with the movement of the sample to be fixed. These parameters include the total number of cycles to which the sample is subjected, the speed of movement of the samples, and the number, position and duration of stops of the sample during each cycle. The microprocessor is interfaced with a 'i 202256~
-~..
-thermocouple which continuously measures the actual temperature of the sample in the capillary tu~e 6. The various parameters of movement of the sample can thus be varied as a function of the measure temperature, under the programmed control of the microprocessor. The microprocessor under programmed control may also govern the movement of the keys 13, the temperature in the compartments 7, lS and 16 and external apparatus, such as a peristaltic pump, governing the movement of the sample in the entry and exit branches. Figure 3 shows three independent keys 13, each associated with a capillary tube 6.
The invention relates to apparatus for repeated automatic execution of a thermal cycle for the treatment of biological samples.
Such an apparatus has numerous applications in biology in general and microbiology in particular. In the latter field, the necessity of treating a biological sample at different temperatures is generally dictated by two basic biological characterics. First, the biological activity of an enzyme is greatly dependent on the temperature. In general, each enzyme has an optimum operating temperature and its activity decreases regularly if one moves away from this temperature. Curves showing the variations in biological activity as a function of temperature may thus be obtained and represent an important characteristic of each enzyme. Secondly, the reaction of molecular hybridisation between two sequences of nucleic acids is directly connected to the temperature. This hybridisation based on the complementarity of the bases between two sequences may occur between two molecules of deoxyribonucleic acid (DNA), between two molecules of ribonucleic acid (RNA) or between one molecule of DNA and one molecule of RNA. Molecular hybridisation enables one to produce either pairing by hydrogenous connection between two distinct molecules or intermolecular pairing between i, ~
~022~6~
two complementary sequences. In the latter case, there is the formation of a so-called secondary structure.of DNA or RNA molecules . The effect of temperature on the hybridisation reaction is essential and each sequence of DNA (or RNA) is defined by its Tm, ie: the temperature at which 50% of the sequences are paired to complementary sequences. The Tm of a precise sequence is evaluated experimentally following the hyperchromicity at 260 nm by spectro-photometry, which accompanies the unpairing (or denaturing) of two complementary sequences of DNA. The whole of the DNA sequences are in the single strand form at high temperature (100C) and the double strand form at low temperature (10-20C).
The Tm of a DNA sequence depends essentially on the following two parameters: the basic sequence and ionic force of the medium. The Tm usually found varies between 20 and 85C. Thus, the great majority of molecular reactions may be produced in perfectly defined and controlled thermal conditions. Certain of these reactions require the successive use of different temperatures and may be effected in the apparatus described in this invention. This particularly concerns hydrolysis using restriction enzymes, enzyme modification reactions for DNA, cascade enzyme reactions, the isolation of repetitive families of sequences for DNA and the amplification by 'polymerase chain reaction'. These applications will now be discussed in greater detail.
Hydrolysis of DNA by restriction enzymes A restriction enzyme enables one to cut a hybridisation duplex DNA/DNA at a very specific place defined by its sequence. For the great majority of these enzymes, the temperature of maximum activity is 37C. The incubation time of DNA with the enzyme at 37C varies between 30 min and several hours . Thus, a simple method of inactivating the enzyme consists of incubating the sample for several 2o2~64 \
-minutes at 100C, a temperature at which the enzyme is irreversibly denatured. This treatment is equally.effective in DNA denaturation which returns to its double strand form if it is subjected to progressive reduction of the temperature from 110C to 20C. Sudden cooling of the sample does not enable one to achieve correct renaturing of the DNA. Progressive cooling in particular may proceed by stages.
Generalisation of the set of enzyme treatments of DNA and lo RNA
This method applied for restriction enzymes may be adapted for the treatment of many enzymes, for example:
- polynucleotic kinases - ligases - the terminal deoxynucleotidyl transferase - DNA and RNA polymerases - endonucleases and exonucleases Cascade enzyme treatment Many successive enzyme treatments may be necessary to obtain one or more defined DNA sequences. A change of the reaction medium is generally necessary between two enzyme reactions.
Isolation of repetitive families of DNA sequences DNA sequences in large numbers exist in complex genomes (human genome = 3.5 x 10 basic pairs). It is possible to distinguish different repetitive families of sequences as a function of the number of copies of sequences per genome.
Thus, DNA genomes totally denatured thermally are restored in stages and in a selective manner. The very repetitive sequences are restored first (family 1), then the medium repetitive sequences (family 2), then the hardly repetitive sequences (family 3) and finally, the unique sequences (family 4). It is thus possible to isolate these i 2~2~
-different families by passing the sample into affinity columns of the hydroxy-apatite type, enabling one to separate single strand DNA molecules from double strand DNA
molecules. They are passed into the columns at a precise temperature during stage by stage cooling of the sample.
The temperature of the first column is around the melting temperature (Tm) of family 1 sequences. In these conditions, sequences of family 1 can be separated from sequences of families 2, 3 and 4. The same process is lo applied for separation of families 2, 3 and 4. The apparatus described in this invention is particularly well adapted to carry out this thermal sequence.
Amplification of the number of DNA sequences by 'Polymerase chain reaction' (PCR) This technique enables one specifically to amplify the number of copies of a double strand DNA sequence. The principle of PCR (R.K. Saiki et al, Science, 230, 198S, 1350-1354) is to use the activity of the DNA polymerase DNA
dependent initiating the synthesis starting from oligonucleotidic initial material (Pl and P2) added in the reaction medium. An amplification cycle consists of three successive stages:
- Staqe 1 Denaturing of the DNA with double strands at 90-lOO~C.
- Stage 2 Hybridisation of oligonucleotidic primers (15-35 nucleotides) P1 and P2 on the target sequences.
Pl hybridizes with the (+) strand and P2 hybridizes with the (-) strand. This stage is carried out at a temperature close to the mean of the Tm's of P1 and P2.
- Stage 3 Synthesis of the complementary DNA strand by extension of the primers Pl and P2, thanks to the activity of a DNA
polymerase. This stage takes place close to the optimum 1, 2 0 ~ J' ~ l~
operating temperature of the enzyme, either at 37C for the Klenow fragment or at 72C for the Tag polymerase~
Thus, after an amplification cycle, the number of sequences completed by Pl and P2 is multiplied by 2, multiplied by 4 after 2 cycles, by 8 after 3 cycles, by 1024 after 10 cycles and by 1,048,576 after 20 cycles. Generally, the rate of amplification after _ cycles is 2n. A cycle of amplification thus consists of 3 successive thermal stages and one complete PCR reaction requires about 10 to 60 cycles. Each thermal stage generally lasts from 1 to 5 mins. Automation of such a technique thus represents considerable progress.
The invention provides apparatus for repeated automatic execution of a thermal cycle for the treatment of a sample, the apparatus comprising means defining a pathway which is physically closed throughout the treatment and within which the sample is resident throughout the treatment, means for moving the sample between different positions along the pathway, and means for heating and cooling the sample as a function of its position within the pathway.
~he means defining the pathway preferably comprises a capillary tube. This may be of a semi-rigid material such as plastics material, and may be of small diameter, from approximately 0.1 mm to approximately 4 mm, preferably from 1 mm to 3 mm. Such a small internal cross-section ensures a large heat exchange surface to volume ratio, and therefore enables rapid temperature variations, particularly as compared to a sample in a conventional 0,5 to 1,5 ml tube. The sample treated in the apparatus of the invention is usually of from 1 to 50 microlitres.
Various spatial arrangements of the capillary tube are envisaged. It may, for instance, be in a spiral form, in a 2~225~
-closed loop form or in linear form. Each turn of the spiral, each turn of the closed loop or each passage of the length of linear capillary tube represents one thermal cycle, within which the sample passes through two or more thermostated zones, at different temperatures from 4C to 150C. Further thermal cycles, up to 100, comprise the next turn of spiral, a further turn within the closed loop, or the return of the sample in reverse direction along the length of the linear capillary tube.
lo The thermostated zones may be arranged on a discontinuous system or on a continuous system. In a discontinuous system, the zones are separated by a physical barrier, crossed only by the capillary tube. Each zone has an autonomous heating or cooling system. The inter-zone barrier isolates each zone from the thermal effect of the adjacent zone(s). In a continuous system there is no physical barrier. The capillary tube crosses a continuous and directional thermal gradient, which may be created in a liquid, gaseous or solid medium. A change of medium gives the possibility of a continuous but irregular thermal gradient.
The rate of movement of the sample through the capillary tube has a profound effect on the treatment. If the sample moves very slowly through a zone, its temperature will approach or reach the zone temperature. The sample may even be stopped within a given zone for a predetermined period, stabilising its temperature at that of the zone. on the other hand, if the sample moves rapidly through a zone, the thermal effect of that zone on the sample may be minimised or suppressed.
The movement of the sample in the capillary tube may be obtained in different ways:
- by at least one peristaltic pump acting on a capillary zone having a flexible wall;
2 ~ ~ 4 -- by displacement in a magnetic system consisting of two parts: .
of a magnet and of a party responding to the effect of the magnet (metal part or second magnet);
One of the parts is solidly connected to a mechanical drive system, enabling it to rotate (circular system) or to be displaced (linear system). The other part is situated inside the capillary and is solidly connected to the sample. This part may consist of at least one solid particle (globule, cylinder, suspension of microparticles in a liquid etc) or at least of one liquid particle.
- by the effect of at least one pump acting on a gas:
- by passive capillary action;
- by the effect of thermal pumping created by the proximity of gaseous masses at different temperatures inside the capillary.
The movement of the sample may also be obtained by a combination of two or more of these processes. The movement of the sample may be under microprocessor control.
The apparatus of the invention uses a semi-closed system, represented by the capillary, reducing the risk of molecular contamination during treatment of the biological sample.
The invention is illustrated with reference to the drawings, of which:
Figures la, lb and lc are schematic diagrams of the apparatus of the invention, showing the helical, closed loop and linear arrangements respectively of the capillary tube; Figure 2 is a cross-sectional view according to the section line II-II of Figure 3 of an apparatus according to the invention in which the capillary tube is of closed loop form; and Figure 3 is a sectional view of the apparatus of Figure 2, taken on the section line II-II of Figure 2.
2022S6~
Reffering first to Figure la-c, three schematic diagrams are presented. In each, there are three thermostated zones I, II and III through which the biological sample in the capillary tube passes in a single thermal cycle. The thermostatic zones I, II and III could be replaced by a continuous or discontinuous thermal gradient. In the spiral form of Figure la, there are as many loops as there are thermal cycles to be performed. In the closed loop form of Figure lb, there is just one loop and each thermal cycle consists of one circuit of the closed loop by the biological sample. In the linear form of Figure lc the first thermal cycle is completed by the passage of the sample from left to right, that is through thermostated zone I, thermostated zone II and thermostated zone III in i~ succession. The second thermal cycle is completed by the return passage of the sample from right to left, that is through thermostated zone III, thermostated zone II and thermostated zone I in succession. Each odd numbered cycle follows the pattern of the first and each even numbered cycle follows the pattern of the second. It is noted that the sample essentially passes through the thermostated zone II in each direction, so producing a succession of thermostated zones I, II, III, III, II, I, I, II, III, III, II, I........ However, the passage through thermostated zone II on even cycles can be completed quickly to minimise its effect, and the delay times in zones I and III adjusted to achieve the same I,II,III,I,II,III,I,II,III... effect as in the spiral and closed loop arrangements.
Reffering now to Figures 2 and 3, the apparatus illustrated shows a closed loop form of the apparatus of the invention, with a magnetic displacement system for the biological sample and a discontinuous system of thermostated zones.
The apparatus is provided with a capillary tube 6 in the form of a closed loop. The capillary tube 6 is provided with a branch e for entry of the sample to be treated, and with a branch s for removal of the sample after treatment.
~02256~
g A key 13 is movable along the axis B-B between a radially inward position, in which the capillary tube 6 is pressed against a wall 5, and a radially outward position, in which the capillary branches e and s are pressed against the elements 14. In the radially inward position, the capillary loop 6 is interrupted and the branches e and s are open for entry and removal of the sample. In the radially outward position the branches e and s are closed, and the sample is free to continue cycling around the closed loop capillary 6. The means for moving the key 13 are external to the apparatus described, and are not shown in the drawings.
For movement of the sample around the closed loop capillary 6, a magnetic system is used. This comprises a magnetic 4 carrled on an arm 2 fast with a drive shaft 3. The drive shaft 3 is journalled at 11 and powered by a motor 12.
Responsive to the effect of the magnetic 2 is a party formed by metallic micro-globules in suspension in mineral oil. This party is in the capillary tube 6 in abutment with the sample.
During one turn of the sample around the closed loop capillary 6, the sample passes close to thermostatic compartments 7, 15 and 16. The sample is under the thermal influence of the compartment in regard of which it finds itself for the time being. Each of these compartments 7, 15 and 16 is thermally regulated at a temperature between 4C
and 150C. The compartments are isolated from a brace 10, carried by a mounting plate 9, by an adjustable spacing 8.
The motor 12 is under the control of a programmable microprocessor, allowing various parameters associated with the movement of the sample to be fixed. These parameters include the total number of cycles to which the sample is subjected, the speed of movement of the samples, and the number, position and duration of stops of the sample during each cycle. The microprocessor is interfaced with a 'i 202256~
-~..
-thermocouple which continuously measures the actual temperature of the sample in the capillary tu~e 6. The various parameters of movement of the sample can thus be varied as a function of the measure temperature, under the programmed control of the microprocessor. The microprocessor under programmed control may also govern the movement of the keys 13, the temperature in the compartments 7, lS and 16 and external apparatus, such as a peristaltic pump, governing the movement of the sample in the entry and exit branches. Figure 3 shows three independent keys 13, each associated with a capillary tube 6.
Claims (17)
1. Apparatus for the treatment of biological and microbiological samples comprising:
(a) a pathway which is physically closed throughout the treatment;
(b) means for introducing one of said biological or microbiological samples to the pathway prior to the commencement of treatment and for removing said sample subsequent to the completion of treatment;
(c) means for physically closing the pathway during treatment so that nothing can be added thereto or withdrawn therefrom;
(d) a plurality of thermal means positioned along the pathway for heating or cooling of said sample, said thermal means providing treatment of said sample at a temperature of from 4°C to 150°C; and (e) means for automatically and repeatedly, through a plurality of cycles, moving said sample between said different thermal positions along the pathway.
(a) a pathway which is physically closed throughout the treatment;
(b) means for introducing one of said biological or microbiological samples to the pathway prior to the commencement of treatment and for removing said sample subsequent to the completion of treatment;
(c) means for physically closing the pathway during treatment so that nothing can be added thereto or withdrawn therefrom;
(d) a plurality of thermal means positioned along the pathway for heating or cooling of said sample, said thermal means providing treatment of said sample at a temperature of from 4°C to 150°C; and (e) means for automatically and repeatedly, through a plurality of cycles, moving said sample between said different thermal positions along the pathway.
2. Apparatus according to claim 1 in which the means defining the pathway comprises a capillary tube.
3. Apparatus according to claim 2 in which the capillary tube is of semi-rigid plastics material.
4. Apparatus according to claim 2 or claim 3 in which the capillary tube has an internal diameter of from 0.1 to 4 mm.
5. Apparatus according to any one of claims 1 to 3 in which the pathway is a spiral pathway.
6. Apparatus according to any one of claims 1 to 3 in which the pathway is a closed loop pathway.
7. Apparatus according to any one of claims 1 to 3 in which the pathway is a linear pathway.
8. Apparatus according to any one of claims 1 to 3 in which the means for heating and cooling the sample comprises two or more thermostated zones through which the pathway passes.
9. Apparatus according to claim 8 in which the thermostated zones are arranged discontinuously, each being separated from the next by a physical barrier crossed only by the pathway and each being provided with an autonomous heating or cooling system.
10. Apparatus according to claim 8 in which the thermostated zones are arranged continuously along the pathway to provide a continuous and directional thermal gradient.
11. Apparatus according to claim 10 in which the thermal gradient is irregular.
12. Apparatus according to any one of claims 1 to 3 in which the means for moving the sample comprises magnetic means including magnetic party within the pathway adjacent to the sample and an external magnet acting on the magnetic party to move it and hence the sample.
13. Apparatus according to claim 12 in which the magnetic party is a solid magnet or a suspension of magnetic microparticles in a liquid immiscible with the sample.
14. Apparatus according to any one of claims 1 to 3 in which the means for moving the sample comprises a pump acting on a gas.
15. Apparatus according to any one of claims 1 to 3 in which the means for moving the sample comprises the effect of thermal pumping created by the proximity of gaseous masses at different temperatures within the pathway.
16. Apparatus according to claim 2 in which the means for moving the sample comprises passive capillary action.
17. Apparatus according to claim 3 in which the means for moving the sample comprises a peristaltic pump.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898917963A GB8917963D0 (en) | 1989-08-05 | 1989-08-05 | Apparatus for repeated automatic execution of a thermal cycle for treatment of biological samples |
| GB8917963.4 | 1989-08-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2022564A1 CA2022564A1 (en) | 1991-02-06 |
| CA2022564C true CA2022564C (en) | 1996-03-05 |
Family
ID=10661242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002022564A Expired - Fee Related CA2022564C (en) | 1989-08-05 | 1990-08-02 | Apparatus for repeated automatic execution of a thermal cycle for treatment of samples |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5176203A (en) |
| JP (1) | JP3058661B2 (en) |
| AR (1) | AR243600A1 (en) |
| AT (1) | AT403165B (en) |
| AU (1) | AU643225B2 (en) |
| BE (1) | BE1004524A3 (en) |
| CA (1) | CA2022564C (en) |
| CH (1) | CH681431A5 (en) |
| DE (1) | DE4024714C2 (en) |
| DK (1) | DK185990A (en) |
| ES (1) | ES2027111A6 (en) |
| FI (1) | FI903856A0 (en) |
| FR (1) | FR2650657A1 (en) |
| GB (2) | GB8917963D0 (en) |
| GR (1) | GR1000653B (en) |
| HK (1) | HK33194A (en) |
| IE (1) | IE65524B1 (en) |
| IN (1) | IN177441B (en) |
| IT (1) | IT1243976B (en) |
| LU (1) | LU87782A1 (en) |
| MA (1) | MA21926A1 (en) |
| MY (1) | MY107255A (en) |
| NL (1) | NL9001772A (en) |
| NO (1) | NO903423L (en) |
| NZ (1) | NZ234736A (en) |
| OA (1) | OA09742A (en) |
| PT (1) | PT94899B (en) |
| SE (1) | SE9002566L (en) |
| TN (1) | TNSN90110A1 (en) |
| ZA (1) | ZA905935B (en) |
Families Citing this family (159)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5935401A (en) * | 1996-09-18 | 1999-08-10 | Aclara Biosciences | Surface modified electrophoretic chambers |
| US6787338B2 (en) * | 1990-06-04 | 2004-09-07 | The University Of Utah | Method for rapid thermal cycling of biological samples |
| FR2672231A1 (en) * | 1991-02-01 | 1992-08-07 | Eibet | Apparatus for repeated automatic execution of a heat cycle, especially for the amplification of the number of a defined nucleic acid sequence |
| US5270183A (en) * | 1991-02-08 | 1993-12-14 | Beckman Research Institute Of The City Of Hope | Device and method for the automated cycling of solutions between two or more temperatures |
| US7297313B1 (en) | 1991-08-31 | 2007-11-20 | The Regents Of The University Of California | Microfabricated reactor, process for manufacturing the reactor, and method of amplification |
| WO1993008297A1 (en) * | 1991-10-23 | 1993-04-29 | Baylor College Of Medicine | Fingerprinting bacterial strains using repetitive dna sequence amplification |
| US5587128A (en) * | 1992-05-01 | 1996-12-24 | The Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification devices |
| US6953676B1 (en) * | 1992-05-01 | 2005-10-11 | Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification device and method |
| US5726026A (en) * | 1992-05-01 | 1998-03-10 | Trustees Of The University Of Pennsylvania | Mesoscale sample preparation device and systems for determination and processing of analytes |
| WO1993022058A1 (en) * | 1992-05-01 | 1993-11-11 | Trustees Of The University Of Pennsylvania | Polynucleotide amplification analysis using a microfabricated device |
| US5498392A (en) * | 1992-05-01 | 1996-03-12 | Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification device and method |
| US5639423A (en) * | 1992-08-31 | 1997-06-17 | The Regents Of The University Of Calfornia | Microfabricated reactor |
| WO1994010564A1 (en) * | 1992-11-05 | 1994-05-11 | Evotec Biosystems Gmbh | Process for separating substances from dilute solutions and suspensions |
| US5433141A (en) * | 1993-04-08 | 1995-07-18 | Kraft Foods, Inc. | Development of a uniform temperature gradient in a block of cheese |
| ATE208658T1 (en) * | 1993-07-28 | 2001-11-15 | Pe Corp Ny | APPARATUS AND METHOD FOR NUCLEIC ACID DUPLICATION |
| CA2130013C (en) * | 1993-09-10 | 1999-03-30 | Rolf Moser | Apparatus for automatic performance of temperature cycles |
| CA2130517C (en) * | 1993-09-10 | 1999-10-05 | Walter Fassbind | Array of reaction containers for an apparatus for automatic performance of temperature cycles |
| US5645801A (en) * | 1993-10-21 | 1997-07-08 | Abbott Laboratories | Device and method for amplifying and detecting target nucleic acids |
| AU8073294A (en) * | 1993-10-21 | 1995-05-08 | Abbott Laboratories | Apparatus and method for transfer of a fluid sample |
| AU1527095A (en) * | 1994-01-11 | 1995-08-01 | Abbott Laboratories | Apparatus and method for thermal cycling nucleic acid assays |
| US5840573A (en) * | 1994-02-01 | 1998-11-24 | Fields; Robert E. | Molecular analyzer and method of use |
| DE4420732A1 (en) * | 1994-06-15 | 1995-12-21 | Boehringer Mannheim Gmbh | Device for the treatment of nucleic acids from a sample |
| DE4435107C1 (en) * | 1994-09-30 | 1996-04-04 | Biometra Biomedizinische Analy | Miniaturized flow thermal cycler |
| AU705351B2 (en) * | 1994-11-10 | 1999-05-20 | Orchid Biosciences, Inc. | Liquid distribution system |
| US5603351A (en) * | 1995-06-07 | 1997-02-18 | David Sarnoff Research Center, Inc. | Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device |
| US5585069A (en) * | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
| US5533567A (en) * | 1994-12-14 | 1996-07-09 | The Regents Of The University Of California | Method and apparatus for uniform heating and cooling |
| US5637226A (en) * | 1995-08-18 | 1997-06-10 | Az Industries, Incorporated | Magnetic fluid treatment |
| CA2236451A1 (en) * | 1995-11-03 | 1997-05-09 | Zygmunt M. Andrevski | Assay system and method for conducting assays |
| US5830657A (en) * | 1996-05-01 | 1998-11-03 | Visible Genetics Inc. | Method for single-tube sequencing of nucleic acid polymers |
| CA2252571A1 (en) * | 1996-05-01 | 1997-11-06 | Visible Genetics Inc. | Method and apparatus for thermal cycling and for automated sample preparation with thermal cycling |
| WO1997048818A1 (en) * | 1996-06-17 | 1997-12-24 | The Board Of Trustees Of The Leland Stanford Junior University | Thermocycling apparatus and method |
| US5795784A (en) | 1996-09-19 | 1998-08-18 | Abbott Laboratories | Method of performing a process for determining an item of interest in a sample |
| US5856194A (en) | 1996-09-19 | 1999-01-05 | Abbott Laboratories | Method for determination of item of interest in a sample |
| GB9621357D0 (en) * | 1996-10-12 | 1996-12-04 | Central Research Lab Ltd | Heating apparatus |
| US5882903A (en) * | 1996-11-01 | 1999-03-16 | Sarnoff Corporation | Assay system and method for conducting assays |
| US6143496A (en) | 1997-04-17 | 2000-11-07 | Cytonix Corporation | Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly |
| DE19717085C2 (en) | 1997-04-23 | 1999-06-17 | Bruker Daltonik Gmbh | Processes and devices for extremely fast DNA multiplication using polymerase chain reactions (PCR) |
| US5965410A (en) | 1997-09-02 | 1999-10-12 | Caliper Technologies Corp. | Electrical current for controlling fluid parameters in microchannels |
| AUPO931797A0 (en) * | 1997-09-22 | 1997-10-09 | Diatech Pty Ltd | Apparatus for amplification and determination of nucleic acids |
| US6174675B1 (en) | 1997-11-25 | 2001-01-16 | Caliper Technologies Corp. | Electrical current for controlling fluid parameters in microchannels |
| US5912129A (en) * | 1998-03-05 | 1999-06-15 | Vinayagamoorthy; Thuraiayah | Multi-zone polymerase/ligase chain reaction |
| DE19980632B4 (en) * | 1998-04-08 | 2005-07-07 | Universität Heidelberg | Process for carrying out reactions between at least two reactants in aqueous reaction mixtures |
| US6780617B2 (en) | 2000-12-29 | 2004-08-24 | Chen & Chen, Llc | Sample processing device and method |
| US7799521B2 (en) * | 1998-06-24 | 2010-09-21 | Chen & Chen, Llc | Thermal cycling |
| AU4957699A (en) * | 1998-06-24 | 2000-01-10 | Chen & Chen, Llc | Fluid sample testing system |
| US6413780B1 (en) * | 1998-10-14 | 2002-07-02 | Abbott Laboratories | Structure and method for performing a determination of an item of interest in a sample |
| US6485690B1 (en) | 1999-05-27 | 2002-11-26 | Orchid Biosciences, Inc. | Multiple fluid sample processor and system |
| US6977145B2 (en) * | 1999-07-28 | 2005-12-20 | Serono Genetics Institute S.A. | Method for carrying out a biochemical protocol in continuous flow in a microreactor |
| AU2756301A (en) * | 2000-01-03 | 2001-07-16 | Panagenic International, Inc. | Compositions comprising genome segments and methods of using the same |
| GB0005434D0 (en) | 2000-03-08 | 2000-04-26 | Secr Defence | Reaction system |
| EP1317569B1 (en) * | 2000-09-14 | 2009-11-18 | Caliper Life Sciences, Inc. | Microfluidic devices and methods for performing temperature mediated reactions |
| JP2003024063A (en) * | 2001-07-12 | 2003-01-28 | Toshio Kawai | Method for continuously amplifying dna and device for the same |
| AUPR707101A0 (en) * | 2001-08-16 | 2001-09-06 | Corbett Research Pty Ltd | Continuous flow thermal device |
| EP1427531B1 (en) * | 2001-09-11 | 2016-10-19 | Iquum, Inc. | Sample vessels |
| KR100442836B1 (en) * | 2001-11-10 | 2004-08-02 | 삼성전자주식회사 | System and method for circulating biochemical fluidic solutions around closed two or more temperature zones of chambers |
| US7179639B2 (en) * | 2002-03-05 | 2007-02-20 | Raveendran Pottathil | Thermal strip thermocycler |
| US6911132B2 (en) * | 2002-09-24 | 2005-06-28 | Duke University | Apparatus for manipulating droplets by electrowetting-based techniques |
| US7329545B2 (en) * | 2002-09-24 | 2008-02-12 | Duke University | Methods for sampling a liquid flow |
| AU2004220626B2 (en) * | 2003-02-05 | 2010-07-29 | Iquum Inc. | Sample processing tubule |
| US7041481B2 (en) | 2003-03-14 | 2006-05-09 | The Regents Of The University Of California | Chemical amplification based on fluid partitioning |
| US20040224425A1 (en) * | 2003-05-08 | 2004-11-11 | Gjerde Douglas T. | Biomolecule open channel solid phase extraction systems and methods |
| CN100434502C (en) * | 2003-07-11 | 2008-11-19 | 太阳诱电株式会社 | Nucleic acid amplifier and method of nucleic acid amplification |
| US8293471B2 (en) * | 2004-01-28 | 2012-10-23 | Marshall University Research Corporation | Apparatus and method for a continuous rapid thermal cycle system |
| CA2553833C (en) * | 2004-01-28 | 2012-10-02 | 454 Corporation | Nucleic acid amplification with continuous flow emulsion |
| EP1733023B1 (en) * | 2004-02-24 | 2013-01-23 | Thermal Gradient | Thermal cycling device |
| US8043849B2 (en) * | 2004-02-24 | 2011-10-25 | Thermal Gradient | Thermal cycling device |
| WO2005094981A1 (en) * | 2004-03-29 | 2005-10-13 | Agilent Technologies, Inc. | Cyclic pcr system |
| US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
| US7398015B2 (en) * | 2004-12-10 | 2008-07-08 | Electronics And Telecommunications Research Institute | Apparatus for controlling fluid-heating using polymer disk |
| EP1859330B1 (en) * | 2005-01-28 | 2012-07-04 | Duke University | Apparatuses and methods for manipulating droplets on a printed circuit board |
| US20060246493A1 (en) | 2005-04-04 | 2006-11-02 | Caliper Life Sciences, Inc. | Method and apparatus for use in temperature controlled processing of microfluidic samples |
| KR101431775B1 (en) | 2005-05-11 | 2014-08-20 | 듀크 유니버서티 | Method and device for conducting biochemical or chemical reactions at multiple temperatures |
| CN101351542A (en) * | 2005-07-15 | 2009-01-21 | 阿普尔拉公司 | Fluid processing device and method |
| US20100137163A1 (en) | 2006-01-11 | 2010-06-03 | Link Darren R | Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors |
| US9476856B2 (en) | 2006-04-13 | 2016-10-25 | Advanced Liquid Logic, Inc. | Droplet-based affinity assays |
| US20140193807A1 (en) | 2006-04-18 | 2014-07-10 | Advanced Liquid Logic, Inc. | Bead manipulation techniques |
| WO2009140373A2 (en) * | 2008-05-13 | 2009-11-19 | Advanced Liquid Logic, Inc. | Droplet actuator devices, systems, and methods |
| US10078078B2 (en) | 2006-04-18 | 2018-09-18 | Advanced Liquid Logic, Inc. | Bead incubation and washing on a droplet actuator |
| US7439014B2 (en) | 2006-04-18 | 2008-10-21 | Advanced Liquid Logic, Inc. | Droplet-based surface modification and washing |
| US8809068B2 (en) | 2006-04-18 | 2014-08-19 | Advanced Liquid Logic, Inc. | Manipulation of beads in droplets and methods for manipulating droplets |
| WO2007123908A2 (en) * | 2006-04-18 | 2007-11-01 | Advanced Liquid Logic, Inc. | Droplet-based multiwell operations |
| US7851184B2 (en) * | 2006-04-18 | 2010-12-14 | Advanced Liquid Logic, Inc. | Droplet-based nucleic acid amplification method and apparatus |
| US8980198B2 (en) * | 2006-04-18 | 2015-03-17 | Advanced Liquid Logic, Inc. | Filler fluids for droplet operations |
| WO2009111769A2 (en) | 2008-03-07 | 2009-09-11 | Advanced Liquid Logic, Inc. | Reagent and sample preparation and loading on a fluidic device |
| US20080003142A1 (en) | 2006-05-11 | 2008-01-03 | Link Darren R | Microfluidic devices |
| US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
| US10741034B2 (en) | 2006-05-19 | 2020-08-11 | Apdn (B.V.I.) Inc. | Security system and method of marking an inventory item and/or person in the vicinity |
| KR101422572B1 (en) * | 2006-09-05 | 2014-07-30 | 삼성전자주식회사 | Centrifugal force-based microfluidic device for nucleic acid detection and microfluidic system comprising the device |
| US8273310B2 (en) * | 2006-09-05 | 2012-09-25 | Samsung Electronics Co., Ltd. | Centrifugal force-based microfluidic device for nucleic acid extraction and microfluidic system including the microfluidic device |
| EP3527671A1 (en) * | 2006-10-06 | 2019-08-21 | Applied DNA Sciences Inc. | System for a continuous rapid thermal cycle system |
| DE102006053451B4 (en) * | 2006-11-11 | 2008-11-27 | Microfluidic Chipshop Gmbh | Microfluidic platform for temperature control of substances and / or for reactions to be tempered |
| US20080176292A1 (en) * | 2007-01-23 | 2008-07-24 | Texas A&M University System | Portable buoyancy driven pcr thermocycler |
| WO2008097559A2 (en) | 2007-02-06 | 2008-08-14 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| EP2573562A3 (en) | 2007-02-09 | 2013-10-30 | Advanced Liquid Logic, Inc. | Droplet actuator devices and methods employing magnetic beads |
| WO2011084703A2 (en) | 2009-12-21 | 2011-07-14 | Advanced Liquid Logic, Inc. | Enzyme assays on a droplet actuator |
| US8592221B2 (en) | 2007-04-19 | 2013-11-26 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| EP2191897B1 (en) | 2007-06-21 | 2014-02-26 | Gen-Probe Incorporated | Instrument and receptacles for performing processes |
| WO2009002920A1 (en) * | 2007-06-22 | 2008-12-31 | Advanced Liquid Logic, Inc. | Droplet-based nucleic acid amplification in a temperature gradient |
| WO2009021233A2 (en) * | 2007-08-09 | 2009-02-12 | Advanced Liquid Logic, Inc. | Pcb droplet actuator fabrication |
| GB2451900A (en) * | 2007-08-17 | 2009-02-18 | Uniqsis Ltd | Flow apparatus |
| US8702938B2 (en) | 2007-09-04 | 2014-04-22 | Advanced Liquid Logic, Inc. | Droplet actuator with improved top substrate |
| US20090263870A1 (en) * | 2007-09-10 | 2009-10-22 | Agency For Science, Technology And Research | System and method for amplifying a nucleic acid molecule |
| CN101945767B (en) | 2007-12-23 | 2013-10-30 | 先进液体逻辑公司 | Droplet actuator configurations and methods of conducting droplet operations |
| WO2009137415A2 (en) | 2008-05-03 | 2009-11-12 | Advanced Liquid Logic, Inc. | Reagent and sample preparation, loading, and storage |
| US20110097763A1 (en) * | 2008-05-13 | 2011-04-28 | Advanced Liquid Logic, Inc. | Thermal Cycling Method |
| WO2010009365A1 (en) | 2008-07-18 | 2010-01-21 | Raindance Technologies, Inc. | Droplet libraries |
| US9156010B2 (en) | 2008-09-23 | 2015-10-13 | Bio-Rad Laboratories, Inc. | Droplet-based assay system |
| US9417190B2 (en) | 2008-09-23 | 2016-08-16 | Bio-Rad Laboratories, Inc. | Calibrations and controls for droplet-based assays |
| US8633015B2 (en) | 2008-09-23 | 2014-01-21 | Bio-Rad Laboratories, Inc. | Flow-based thermocycling system with thermoelectric cooler |
| US8709762B2 (en) | 2010-03-02 | 2014-04-29 | Bio-Rad Laboratories, Inc. | System for hot-start amplification via a multiple emulsion |
| US9764322B2 (en) | 2008-09-23 | 2017-09-19 | Bio-Rad Laboratories, Inc. | System for generating droplets with pressure monitoring |
| US9492797B2 (en) | 2008-09-23 | 2016-11-15 | Bio-Rad Laboratories, Inc. | System for detection of spaced droplets |
| US10512910B2 (en) | 2008-09-23 | 2019-12-24 | Bio-Rad Laboratories, Inc. | Droplet-based analysis method |
| WO2011120020A1 (en) | 2010-03-25 | 2011-09-29 | Quantalife, Inc. | Droplet transport system for detection |
| US9132394B2 (en) | 2008-09-23 | 2015-09-15 | Bio-Rad Laboratories, Inc. | System for detection of spaced droplets |
| US8951939B2 (en) | 2011-07-12 | 2015-02-10 | Bio-Rad Laboratories, Inc. | Digital assays with multiplexed detection of two or more targets in the same optical channel |
| US11130128B2 (en) | 2008-09-23 | 2021-09-28 | Bio-Rad Laboratories, Inc. | Detection method for a target nucleic acid |
| US8926065B2 (en) | 2009-08-14 | 2015-01-06 | Advanced Liquid Logic, Inc. | Droplet actuator devices and methods |
| EP2940153B1 (en) * | 2009-09-02 | 2020-05-13 | Bio-Rad Laboratories, Inc. | System for mixing fluids by coalescence of multiple emulsions |
| WO2011057197A2 (en) | 2009-11-06 | 2011-05-12 | Advanced Liquid Logic, Inc. | Integrated droplet actuator for gel electrophoresis and molecular analysis |
| WO2011100604A2 (en) | 2010-02-12 | 2011-08-18 | Raindance Technologies, Inc. | Digital analyte analysis |
| US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
| US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
| US8399198B2 (en) | 2010-03-02 | 2013-03-19 | Bio-Rad Laboratories, Inc. | Assays with droplets transformed into capsules |
| EP2550351A4 (en) | 2010-03-25 | 2014-07-09 | Quantalife Inc | Detection system for droplet-based assays |
| EP2550528B1 (en) | 2010-03-25 | 2019-09-11 | Bio-Rad Laboratories, Inc. | Droplet generation for droplet-based assays |
| EP3447155A1 (en) | 2010-09-30 | 2019-02-27 | Raindance Technologies, Inc. | Sandwich assays in droplets |
| CA3140602C (en) | 2010-11-01 | 2023-10-03 | Bio-Rad Laboratories, Inc. | System for forming emulsions |
| US9364803B2 (en) | 2011-02-11 | 2016-06-14 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
| US9150852B2 (en) | 2011-02-18 | 2015-10-06 | Raindance Technologies, Inc. | Compositions and methods for molecular labeling |
| AU2012231098B2 (en) | 2011-03-18 | 2016-09-29 | Bio-Rad Laboratories, Inc. | Multiplexed digital assays with combinatorial use of signals |
| EP2702175B1 (en) | 2011-04-25 | 2018-08-08 | Bio-Rad Laboratories, Inc. | Methods and compositions for nucleic acid analysis |
| WO2012154745A2 (en) | 2011-05-09 | 2012-11-15 | Advanced Liquid Logic, Inc. | Microfluidic feedback using impedance detection |
| WO2012167142A2 (en) | 2011-06-02 | 2012-12-06 | Raindance Technolgies, Inc. | Enzyme quantification |
| BR112014000257A2 (en) | 2011-07-06 | 2017-03-01 | Advanced Liquid Logic Inc | reagent storage in a drop actuator |
| WO2013009927A2 (en) | 2011-07-11 | 2013-01-17 | Advanced Liquid Logic, Inc. | Droplet actuators and techniques for droplet-based assays |
| US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
| US9446404B2 (en) | 2011-07-25 | 2016-09-20 | Advanced Liquid Logic, Inc. | Droplet actuator apparatus and system |
| WO2013019751A1 (en) | 2011-07-29 | 2013-02-07 | Bio-Rad Laboratories, Inc., | Library characterization by digital assay |
| US10731199B2 (en) | 2011-11-21 | 2020-08-04 | Advanced Liquid Logic, Inc. | Glucose-6-phosphate dehydrogenase assays |
| WO2013155531A2 (en) | 2012-04-13 | 2013-10-17 | Bio-Rad Laboratories, Inc. | Sample holder with a well having a wicking promoter |
| WO2014004908A1 (en) | 2012-06-27 | 2014-01-03 | Advanced Liquid Logic Inc. | Techniques and droplet actuator designs for reducing bubble formation |
| US20140255270A1 (en) * | 2013-02-28 | 2014-09-11 | California Institute Of Technology | Removing sacrificial layer to form liquid containment structure and methods of use thereof |
| US9963740B2 (en) | 2013-03-07 | 2018-05-08 | APDN (B.V.I.), Inc. | Method and device for marking articles |
| US9168533B2 (en) * | 2013-07-17 | 2015-10-27 | CrackerBio, Inc. | Thermal cycler device |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US9904734B2 (en) | 2013-10-07 | 2018-02-27 | Apdn (B.V.I.) Inc. | Multimode image and spectral reader |
| US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| US10745825B2 (en) | 2014-03-18 | 2020-08-18 | Apdn (B.V.I.) Inc. | Encrypted optical markers for security applications |
| CN106103121B (en) | 2014-03-18 | 2019-12-06 | 亚普蒂恩(B.V.I.)公司 | Encrypted optical marker for security applications |
| JP2015223130A (en) * | 2014-05-28 | 2015-12-14 | セイコーエプソン株式会社 | Substance amplification reaction device, and substance amplification method |
| KR102415232B1 (en) * | 2015-04-20 | 2022-07-04 | 한국전자통신연구원 | Micro heating device |
| US11260386B2 (en) | 2015-06-05 | 2022-03-01 | The Emerther Company | Component of a device, a device, and a method for purifying and testing biomolecules from biological samples |
| US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
| WO2017180302A1 (en) | 2016-04-11 | 2017-10-19 | Apdn (B.V.I.) Inc. | Method of marking cellulosic products |
| US10995371B2 (en) | 2016-10-13 | 2021-05-04 | Apdn (B.V.I.) Inc. | Composition and method of DNA marking elastomeric material |
| WO2018156352A1 (en) | 2017-02-21 | 2018-08-30 | Apdn (B.V.I) Inc. | Nucleic acid coated submicron particles for authentication |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA596284A (en) * | 1960-04-19 | M. Findlay Jacquelyn | Electromagnetic liquid metal pump | |
| DE1887821U (en) * | 1964-02-20 | Berliner Quarz Schmelze mbH Mainz | Instantaneous water heater 8 62 B | |
| US2698127A (en) * | 1949-04-06 | 1954-12-28 | Claude A Bowlus | Hydraulic transmission unit, pump, or compressor |
| US2863922A (en) * | 1956-10-02 | 1958-12-09 | Hoffmann La Roche | Preparation of ketene |
| GB823110A (en) * | 1957-03-26 | 1959-11-04 | Leslie Reginald Blake | Improvements relating to electromagnetic interaction pumps |
| US2964532A (en) * | 1957-04-17 | 1960-12-13 | Du Pont | Production of pigments |
| US3574485A (en) * | 1958-11-28 | 1971-04-13 | Broido Louis | Method and apparatus for movement of liquids by electromagnetic means |
| US3108060A (en) * | 1960-05-10 | 1963-10-22 | Phillips Petroleum Co | Loop reactor and process for sulfonating asphalt |
| US3354642A (en) * | 1965-05-18 | 1967-11-28 | Gen Motors Corp | Turbomagnetic pump |
| US3488152A (en) * | 1966-03-16 | 1970-01-06 | United Aircraft Corp | Boron production |
| US3518057A (en) * | 1966-04-22 | 1970-06-30 | Huron Road Hospital | Method and apparatus for thrombus formation time determinations |
| US3411884A (en) * | 1967-04-11 | 1968-11-19 | Atomic Energy Commission Usa | Process for concentrating heavy water |
| US3613386A (en) * | 1970-03-23 | 1971-10-19 | Air Prod & Chem | Cryogenic freezer control |
| US3699004A (en) * | 1970-08-31 | 1972-10-17 | Technicon Instr | Method and apparatus for sample analysis on a continuous flow basis |
| US3738815A (en) * | 1970-10-09 | 1973-06-12 | Dow Chemical Co | Reactor for removing olefins from acetylenic and olefin-containing gaseous hydrocarbon mixtures |
| US4015943A (en) * | 1972-12-15 | 1977-04-05 | Chemische Werke Huls Aktiengesellschaft | Apparatus for the esterification of terephthalic acid in the gas phase |
| US4113435A (en) * | 1973-07-16 | 1978-09-12 | Massachusetts Institute Of Technology | Cryogenically controlled direct fluorination apparatus |
| US3933200A (en) * | 1974-06-21 | 1976-01-20 | Emerson Electric Co. | Temperature conditioning means |
| FR2311764A1 (en) * | 1975-05-23 | 1976-12-17 | Rhone Poulenc Ind | METHOD AND APPARATUS FOR THERMAL TRANSFORMATION OF GYPSUM |
| US4095952A (en) * | 1976-03-16 | 1978-06-20 | Veb Jenapharm Jena | Apparatus for making (DL) pantolactone |
| US4181576A (en) * | 1977-03-29 | 1980-01-01 | Phillips Petroleum Company | Fermentation method |
| US4137966A (en) * | 1977-04-19 | 1979-02-06 | The United States Of America As Represented By The Secretary Of The Navy | Simulation oven |
| US4372918A (en) * | 1978-11-15 | 1983-02-08 | Woods Verle W | Flow through pressure reaction apparatus |
| US4276174A (en) * | 1980-03-26 | 1981-06-30 | Union Carbide Corporation | Control of sludge temperature in autothermal sludge digestion |
| EP0094458A1 (en) * | 1982-05-17 | 1983-11-23 | András Tejfalussy | Temperature distribution regulating sample holder-adapter for forming conditions for gradient heat treatment in heat treatment ovens or furnaces |
| DE3421778A1 (en) * | 1984-06-12 | 1986-01-02 | Karl Dr. 7800 Freiburg Fritz | Microwave heating method |
| FR2555363B1 (en) * | 1983-11-18 | 1986-02-21 | Cit Alcatel | COMPONENT TRANSFER MACHINE FOR HYBRID CIRCUITS |
| US4544025A (en) * | 1984-01-17 | 1985-10-01 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | High gradient directional solidification furnace |
| IE58568B1 (en) * | 1984-11-15 | 1993-10-06 | Suiker Unie | Method and device for the carrying out of a microbiological or enzymatic process |
| US5038852A (en) * | 1986-02-25 | 1991-08-13 | Cetus Corporation | Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps |
| CA1339653C (en) * | 1986-02-25 | 1998-02-03 | Larry J. Johnson | Appartus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps |
| CA1338457C (en) * | 1986-08-22 | 1996-07-16 | Henry A. Erlich | Purified thermostable enzyme |
| JPS63174555A (en) * | 1987-01-12 | 1988-07-19 | Power Reactor & Nuclear Fuel Dev Corp | Conductive electromagnetic pump |
| FI77055C (en) * | 1987-05-15 | 1989-01-10 | Limitek Oy | Thermal gradient-incubator |
| JPS6426360A (en) * | 1987-07-22 | 1989-01-27 | Hitachi Ltd | Superconducting piping device |
| CA1293217C (en) * | 1987-11-09 | 1991-12-17 | Sooyoung Stanford Lee | Controlled growth rate fermentation |
| FI79342C (en) * | 1987-12-23 | 1989-12-11 | Orion Yhtymae Oy | APPARATUS, DEL AV EN APPARAT OCH FOERFARANDE FOER MAONGFALDIGANDE AV NUKLEINSYROR. |
| GB8807297D0 (en) * | 1988-03-26 | 1988-04-27 | Dean P D G | Intelligent heating block |
| DE8813773U1 (en) * | 1988-11-03 | 1989-01-05 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften Ev, 3400 Goettingen, De | |
| DE8814398U1 (en) * | 1988-11-17 | 1989-02-16 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften Ev, 3400 Goettingen, De |
-
1989
- 1989-08-05 GB GB898917963A patent/GB8917963D0/en active Pending
-
1990
- 1990-07-25 IN IN753DE1990 patent/IN177441B/en unknown
- 1990-07-27 ZA ZA905935A patent/ZA905935B/en unknown
- 1990-07-30 AR AR90317498A patent/AR243600A1/en active
- 1990-07-31 US US07/560,107 patent/US5176203A/en not_active Expired - Lifetime
- 1990-07-31 GR GR900100580A patent/GR1000653B/en unknown
- 1990-08-01 GB GB9016886A patent/GB2238005B/en not_active Expired - Fee Related
- 1990-08-01 BE BE9000765A patent/BE1004524A3/en not_active IP Right Cessation
- 1990-08-01 JP JP2202597A patent/JP3058661B2/en not_active Expired - Fee Related
- 1990-08-01 NZ NZ234736A patent/NZ234736A/en unknown
- 1990-08-02 LU LU87782A patent/LU87782A1/en unknown
- 1990-08-02 AT AT0163290A patent/AT403165B/en not_active IP Right Cessation
- 1990-08-02 CA CA002022564A patent/CA2022564C/en not_active Expired - Fee Related
- 1990-08-02 FR FR9009894A patent/FR2650657A1/en active Granted
- 1990-08-02 TN TNTNSN90110A patent/TNSN90110A1/en unknown
- 1990-08-03 FI FI903856A patent/FI903856A0/en not_active Application Discontinuation
- 1990-08-03 PT PT94899A patent/PT94899B/en not_active IP Right Cessation
- 1990-08-03 IT IT02120990A patent/IT1243976B/en active IP Right Grant
- 1990-08-03 CH CH2552/90A patent/CH681431A5/fr not_active IP Right Cessation
- 1990-08-03 DK DK185990A patent/DK185990A/en not_active Application Discontinuation
- 1990-08-03 DE DE4024714A patent/DE4024714C2/en not_active Expired - Fee Related
- 1990-08-03 OA OA59829A patent/OA09742A/en unknown
- 1990-08-03 IE IE281390A patent/IE65524B1/en not_active IP Right Cessation
- 1990-08-03 NO NO90903423A patent/NO903423L/en unknown
- 1990-08-03 AU AU60148/90A patent/AU643225B2/en not_active Ceased
- 1990-08-03 ES ES9002110A patent/ES2027111A6/en not_active Expired - Fee Related
- 1990-08-03 SE SE9002566A patent/SE9002566L/en not_active Application Discontinuation
- 1990-08-04 MY MYPI90001306A patent/MY107255A/en unknown
- 1990-08-06 MA MA22196A patent/MA21926A1/en unknown
- 1990-08-06 NL NL9001772A patent/NL9001772A/en active Search and Examination
-
1994
- 1994-04-14 HK HK33194A patent/HK33194A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2022564C (en) | Apparatus for repeated automatic execution of a thermal cycle for treatment of samples | |
| US6054263A (en) | Thermal cycler including a temperature gradient block | |
| Saiki | The design and optimization of the PCR | |
| CA2713101C (en) | Method for a continuous rapid thermal cycle system | |
| Barik | Site-directed mutagenesis by double polymerase chain reaction: megaprimer method | |
| EP0236069B1 (en) | Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps | |
| US6242222B1 (en) | Programmed sequential mutagenesis | |
| US8293471B2 (en) | Apparatus and method for a continuous rapid thermal cycle system | |
| US5038852A (en) | Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps | |
| Weier et al. | A programmable system to perform the polymerase chain reaction | |
| WO2001062389A2 (en) | Thermal cycler allowing two-dimension temperature gradient generation and hold time optimization | |
| WO1992007089A1 (en) | Method and device for amplification of dna | |
| Barik | Mutagenesis and gene fusion by megaprimer PCR | |
| AU724804B2 (en) | Assay involving looped nucleic acid | |
| Li et al. | Rapid detection of genetically modified organisms on a continuous-flow polymerase chain reaction microfluidics | |
| Hsu et al. | Polymerase chain reaction engineering | |
| Wittwer et al. | Rapid polymerase chain reaction and melting analysis | |
| KR100740869B1 (en) | Method and apparatus for amplification of nucleic acid sequences using immobilized dna polymerase | |
| Peters et al. | PCR on a Roller Coaster | |
| Wittwer et al. | 4 Rapid polymerase chain reaction and melting analysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |